Science
Mechanism of Action
As a histone deacetylase (HDAC) inhibitor, valproic acid activates the Wnt/β-catenin pathway and inhibits glycogen synthase kinase 3β (GSK-3β), mechanisms linked to hair growth. It also reduces inflammation, decreases sebum production, and exhibits antibacterial and antifungal properties on the skin.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 A 12.5% w/v topical gel has shown efficacy in treating various skin conditions, including acne, psoriasis, and eczema.
- 02 An 8.3% topical sodium valproate spray significantly increased total hair counts in male patients with moderate androgenetic alopecia over 24 weeks.
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Valproic acid (pKa 4.6-4.8) is stable at room temperature, with optimal stability generally expected at or below its pKa. Its sodium salt, sodium valproate, is highly water-soluble and stable at pH 7-8.
Conflicts
- Systemic absorption from topical application may interact with certain medications, including anticoagulants and anti-seizure drugs.
- Other skincare products could potentially interfere with its absorption or efficacy.
Safety
Safety Profile
While oral valproic acid is an FDA narrow therapeutic index drug, topical application has shown minimal irritation potential in a clinical study. However, some reports indicate it may cause transient skin irritation, redness, or a burning sensation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Valproic acid offers a targeted solution for multiple skin concerns, including hair loss, acne, and inflammation, demonstrating efficacy at specific topical concentrations with generally low irritation potential.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources